Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman announced that a securities class-action lawsuit has been filed against Replimune Group (NASDAQ: REPL) and certain company officers. The notice introduces legal and reputational risk for the biotech company, although the announcement provides no details on allegations, damages, or potential financial exposure.